Science surrounding the safe use of bioactive ingredients in infant formula: federal comment.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 36759748.
- Also identified by DOI 10.1038/s41390-023-02512-6 and PMC identifier 10382303.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Less than a quarter of U.S. infants meet the federal recommendation for exclusively breastfeeding to 6 months of age, necessitating access to safe and effective infant formula. The U.S. National Institutes of Health (NIH) and Food and Drug Administration (FDA) held a public Workshop titled “Exploring the Science Surrounding the Safe Use of Bioactive Ingredients in Infant Formula: Considerations for an Assessment Framework” on September 23<sup>rd</sup> and September 24<sup>th</sup>, 2021. Commentary from the NIH and FDA perspectives on the workshop topics is provided in this publication.
Medical subject headings
- Infant Formula